Luminal breast cancers are driven by estrogen signaling through ERα, which regulates genes involved in cell proliferation, while dysregulation of this pathway—particularly Via PI3K/AKT/mTOR activation due to PIK3CA mutations and PTEN loss—promotes tumor growth. This evidence concerns the gene ESR1 and breast carcinoma.